Costa Rica vs Malaysia: Access to anti-retroviral drugs, female
Costa Rica
65.0%
in 2024
Malaysia
65.0%
in 2024
Costa Rica rank
91st
Malaysia rank
91st
Access to anti-retroviral drugs, female over time
- Costa Rica
- Malaysia
How they compare
Costa Rica currently reports 65.0% against 65.0% in Malaysia, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 91st and Malaysia ranks 91st of 141 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Malaysia in 2.
Head to head by decade
| Decade | Costa Rica | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.5% | 17.1% | 9.4% | Costa Rica |
| 2010s | 43.0% | 52.0% | 9.0% | Malaysia |
| 2020s | 60.2% | 66.2% | 6.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Costa Rica or Malaysia?
- Costa Rica, at 65.0% against 65.0% in Malaysia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Costa Rica and Malaysia?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Malaysia rank globally for access to anti-retroviral drugs, female?
- Costa Rica ranks 91st and Malaysia ranks 91st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.